Aspen Pharmacare (APNHY.PK) is likely to be a very frustrating stock to many SA readers. While this company may be one of the best publicly-traded plays on the growth of the healthcare markets in Africa, Latin America, and Asia, the stock already sports a very steep multiple. What's more, its ADR shares are incredibly illiquid in the U.S., and only the Johannesburg-traded shares (APNJ.J) offer much liquidity. But for investors who can be patient, an opportunity to acquire shares in this company could be one of those rare once-in-a-decade opportunities.
South Africa Today, Australia Tomorrow, And Then The World...
Aspen Pharmacare is one of the largest emerging market/developing world drug companies. Combining branded drugs, generics, and OTC, Aspen...